{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T11:00:24Z","timestamp":1783162824882,"version":"3.54.6"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jconrel.2022.05.059","type":"journal-article","created":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T12:54:19Z","timestamp":1656161659000},"page":"760-770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Mechanisms of cellular retention of melanin bound drugs: Experiments and computational modeling"],"prefix":"10.1016","volume":"348","author":[{"given":"Sina","family":"Bahrpeyma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Reinisalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Hellinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seppo","family":"Auriola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva M.","family":"del Amo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arto","family":"Urtti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.05.059_bb0005","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","article-title":"Challenges and obstacles of ocular pharmacokinetics and drug delivery","volume":"58","author":"Urtti","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0010","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/j.ophtha.2009.05.026","article-title":"Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients","volume":"116","author":"Okeke","year":"2009","journal-title":"Ophthalmology."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0015","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/pharmaceutics13010028","article-title":"Novel drug delivery systems fighting glaucoma: formulation obstacles and solutions","volume":"13","author":"Rahi\u0107","year":"2021","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2020.01.057","article-title":"Advances and limitations of drug delivery systems formulated as eye drops","volume":"321","author":"Jumelle","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.05.059_bb0025","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","article-title":"Pharmacokinetic aspects of retinal drug delivery","volume":"57","author":"Del Amo","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-3-642-69222-2_2","article-title":"Pharmacology of the eye","volume":"69","author":"Maurice","year":"1984","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0035","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejpb.2015.01.003","article-title":"Intravitreal clearance and volume of distribution of compounds in rabbits: in silico prediction and pharmacokinetic simulations for drug development","volume":"95","author":"del Amo","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0040","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drudis.2007.11.002","article-title":"Current and future ophthalmic drug delivery systems: a shift to the posterior segment","volume":"13","author":"Del Amo","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2022.05.059_bb0045","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1751-1097.2008.00316.x","article-title":"Role of ocular melanin in ophthalmic physiology and pathology","volume":"84","author":"Hu","year":"2008","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0050","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s11095-007-9342-0","article-title":"Binding of betaxolol, metoprolol and oligonucleotides to synthetic and bovine ocular melanin, and prediction of drug binding to melanin in human choroid-retinal pigment epithelium","volume":"24","author":"Pitk\u00e4nen","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0055","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1211\/0022357023141","article-title":"Absorption, distribution and excretion of 14C-levofloxacin after single oral administration in albino and pigmented rats: binding characteristics of levofloxacin-related radioactivity to melanin in vivo","volume":"56","author":"Tanaka","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0060","first-page":"248","article-title":"Beta-adrenergic blockers: ocular penetration and binding to the uveal pigment","volume":"26","author":"Araie","year":"1982","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0065","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1080\/02713683.2016.1238941","article-title":"The relationship of brimonidine concentration in vitreous body to the free concentration in retina\/choroid following topical administration in pigmented rabbits","volume":"42","author":"Shinno","year":"2017","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0070","first-page":"671","article-title":"An explanation for the long duration of mydriatic effect of atropine in eye","volume":"15","author":"Salazar","year":"1976","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0378-5173(84)90132-7","article-title":"Effect of ocular pigmentation on pilocarpine pharmacology in the rabbit eye. II. Drug response","volume":"19","author":"Urtti","year":"1984","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0080","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1167\/iovs.12-10169","article-title":"Assessing a novel depot delivery strategy for noninvasive administration of VEGF\/PDGF RTK inhibitors for ocular neovascular disease","volume":"54","author":"Robbie","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0085","doi-asserted-by":"crossref","first-page":"10106","DOI":"10.1021\/acs.jmedchem.8b01281","article-title":"Understanding molecular drivers of melanin binding to support rational Design of Small Molecule Ophthalmic Drugs","volume":"61","author":"Jakubiak","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0090","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1002\/jps.24680","article-title":"High-throughput melanin-binding affinity and in silico methods to aid in the prediction of drug exposure in ocular tissue","volume":"104","author":"Reilly","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0095","doi-asserted-by":"crossref","DOI":"10.1021\/acs.molpharmaceut.9b00769","article-title":"Establishment of an in vitro-in vivo correlation for melanin binding and the extension of the ocular half-life of small-molecule drugs","author":"Jakubiak","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.addr.2017.12.008","article-title":"Implications of melanin binding in ocular drug delivery","volume":"126","author":"Rimpel\u00e4","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0105","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1021\/acs.molpharmaceut.5b00787","article-title":"Drug distribution to retinal pigment epithelium: studies on melanin binding, cellular kinetics, and single photon emission computed tomography\/computed tomography imaging","volume":"13","author":"Rimpel\u00e4","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0160352","article-title":"Isolation of intact and functional melanosomes from the retinal pigment epithelium","volume":"11","author":"Pelkonen","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.05.059_bb0115","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/exer.1996.0020","article-title":"ARPE-19, a human retinal pigment epithelial cell line with differentiated properties","volume":"62","author":"Dunn","year":"1996","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-50324-8","article-title":"Characterization of artificially re-pigmented ARPE-19 retinal pigment epithelial cell model","volume":"9","author":"Hellinen","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0125","first-page":"127","volume":"106","author":"Mazzei","year":"2010","journal-title":"A RTICLE A Low Shear Stress Modular Bioreactor for Connected Cell Culture Under High Flow Rates"},{"key":"10.1016\/j.jconrel.2022.05.059_bb0130","series-title":"New Technol. Toxic. Test","first-page":"138","article-title":"Engineering Quasi-Vivo\u00ae in Vitro Organ Models","author":"Sbrana","year":"2012"},{"key":"10.1016\/j.jconrel.2022.05.059_bb0135","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jconrel.2018.05.034","article-title":"Melanin targeting for intracellular drug delivery: quantification of bound and free drug in retinal pigment epithelial cells","volume":"283","author":"Rimpel\u00e4","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.05.059_bb0140","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1063\/1.1746922","article-title":"On the structure of a catalyst surface","volume":"16","author":"Sips","year":"1948","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0145","first-page":"1","article-title":"Microscale thermophoresis as a screening tool to predict melanin binding of","author":"Hellinen","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.jconrel.2022.05.059_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/ps060213","article-title":"Permeability classification of representative fluoroquinolones by a cell culture method","volume":"6","author":"Volpe","year":"2004","journal-title":"AAPS PharmSci."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0155","volume":"50","author":"Robertson","year":"2005","journal-title":"Ocular Pharmacokinetics of Moxifloxacin After Topical Treatment of Animals and Humans"},{"key":"10.1016\/j.jconrel.2022.05.059_bb0160","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0161-6420(94)31305-4","article-title":"Retinal photoreceptor count, retinal surface area, and optic disc size in normal human eyes","volume":"101","author":"Panda-Jonas","year":"1994","journal-title":"Ophthalmology."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0165","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1167\/iovs.04-1051","article-title":"Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity","volume":"46","author":"Pitk\u00e4nen","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0170","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jconrel.2018.05.034","article-title":"Melanin targeting for intracellular drug delivery: quantification of bound and free drug in retinal pigment epithelial cells","volume":"283","author":"Rimpel\u00e4","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.05.059_bb0175","first-page":"195","article-title":"Aging human RPE: morphometric analysis of macular, equatorial, and peripheral cells","volume":"25","author":"Feeney-Burns","year":"1984","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0180","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-3565(25)30482-9","article-title":"Iris pigmentation and atropine mydriasis","volume":"197","author":"Salazar","year":"1976","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0185","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1021\/acs.molpharmaceut.6b00782","article-title":"LC-MS\/MS based quantitation of ABC and SLC transporter proteins in plasma membranes of cultured primary human retinal pigment epithelium cells and immortalized ARPE19 cell line","volume":"14","author":"Pelkonen","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0190","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejps.2017.07.027","article-title":"Melanin binding study of clinical drugs with cassette dosing and rapid equilibrium dialysis inserts","volume":"109","author":"Pelkonen","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0195","first-page":"32","article-title":"Binding of antiglaucomatous drugs to synthetic melanin and their hypotensive effects on pigmented and nonpigmented rabbit eyes","volume":"37","author":"Nagata","year":"1993","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0200","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0378-5173(84)90103-0","article-title":"Effect of ocular pigmentation on pilocarpine pharmacology in the rabbit eye. I. Drag distribution and metabolism","volume":"18","author":"Salminen","year":"1984","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0205","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0378-5173(82)90051-5","article-title":"Disposition of pilocarpine in the pigmented rabbit eye","volume":"11","author":"Lee","year":"1982","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0210","doi-asserted-by":"crossref","unstructured":"P. AULA, T. KAILA, R. HUUPPONEN, L. SALMINEN, Timolol binding to bovine ocular melanin in vitro, J. Ocul. Pharmacol. Ther. 4 (1988) 29\u201336.","DOI":"10.1089\/jop.1988.4.29"},{"key":"10.1016\/j.jconrel.2022.05.059_bb0215","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1021\/acs.molpharmaceut.5b00783","article-title":"Interpretation of ocular melanin drug binding assays. Alternatives to the model of multiple classes of independent sites","volume":"13","author":"Manzanares","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0220","first-page":"100","article-title":"Prostaglandin Fz","author":"Auld","year":"1989","journal-title":"Binding to Bovine Ocular and Synthetic Melanins"},{"key":"10.1016\/j.jconrel.2022.05.059_bb0225","first-page":"229","article-title":"Binding of chlorpromazine to cultured retinal pigment epithelial cells loaded with melanin","volume":"6","author":"Basu","year":"1989","journal-title":"Lens Eye Toxic. Res."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0230","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/biot.201000326","article-title":"Modular bioreactor for primary human hepatocyte culture: medium flow stimulates expression and activity of detoxification genes","volume":"6","author":"Vinci","year":"2011","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0235","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/biot.201400004","article-title":"A novel dual-flow bioreactor simulates increased fluorescein permeability in epithelial tissue barriers","volume":"9","author":"Giusti","year":"2014","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2020.104815","article-title":"Microfluidic chip for culturing intestinal epithelial cell layers: characterization and comparison of drug transport between dynamic and static models","volume":"65","author":"Kulthong","year":"2020","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0245","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1167\/iovs.19-27328","article-title":"Quantitative protein expression in the human retinal pigment epithelium: comparison between apical and basolateral plasma membranes with emphasis on transporters","volume":"60","author":"Hellinen","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0250","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0006-3495(93)81179-2","article-title":"Cytoplasmic viscosity near the cell plasma membrane: measurement by evanescent field frequency-domain microfluorimetry","volume":"65","author":"Bicknese","year":"1993","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0255","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0968-0004(01)02003-5","article-title":"Solute and macromolecule diffusion in cellular aqueous compartments","volume":"27","author":"Verkman","year":"2002","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0260","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0074-7696(08)60527-6","article-title":"Cytoarchitecture and physical properties of cytoplasm: volume, viscosity, diffusion, intracellular surface area","volume":"192","author":"Luby-Phelps","year":"1999","journal-title":"Int. Rev. Cytol."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0265","doi-asserted-by":"crossref","unstructured":"C. Durairaj, J.E. Chastain, U.B. Kompella, Intraocular distribution of melanin in human, monkey, rabbit, minipig and dog eyes, Exp. Eye Res. 98 (2012) 23\u201327. doi:https:\/\/doi.org\/10.1016\/j.exer.2012.03.004.","DOI":"10.1016\/j.exer.2012.03.004"},{"key":"10.1016\/j.jconrel.2022.05.059_bb0270","first-page":"145","article-title":"Retinal pigment epithelial lipofuscin and melanin and choroidal melanin in human eyes","volume":"27","author":"Weiter","year":"1986","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0275","volume":"2013","author":"May","year":"2013","journal-title":"Chronologic versus Biologic Aging of the Human Choroid"},{"key":"10.1016\/j.jconrel.2022.05.059_bb0280","first-page":"36","article-title":"Aging changes in lipofuscin, lysosomes and melanin in the macular area of human retina and choroid","volume":"33","author":"Hayasaka","year":"1989","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0285","first-page":"1063","article-title":"Melanin concentration in normal human retinal pigment epithelium. Regional variation and age-related reduction","volume":"27","author":"Schmidt","year":"1986","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0290","article-title":"Binding of Timolol to Iris-ciliary body and melanin\u202f: an in vitro model for assessing the kinetics and efficacy of long-acting Antiglaucoma","volume":"5","author":"Menon","year":"1989","journal-title":"Drugs"},{"key":"10.1016\/j.jconrel.2022.05.059_bb0295","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1021\/acs.molpharmaceut.9b00157","article-title":"Influence of melanin characteristics on drug binding properties","volume":"16","author":"Jakubiak","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0300","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9394(14)70583-5","article-title":"Retinal pigment epithelial cell count, distribution, and correlations in normal human eyes","volume":"121","author":"Panda-Jonas","year":"1996","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0305","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0192623307310955","article-title":"Safety evaluation of ocular drug delivery formulations: techniques and practical considerations","volume":"36","author":"Short","year":"2008","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0310","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3390\/pharmaceutics12121174","article-title":"Quantification of drugs in distinctly separated ocular substructures of albino and pigmented rats","volume":"12","author":"Rimpel\u00e4","year":"2020","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.jconrel.2022.05.059_bb0315","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1021\/acs.molpharmaceut.5b00729","article-title":"Prediction of ocular drug distribution from systemic blood circulation","volume":"13","author":"Vellonen","year":"2016","journal-title":"Mol. Pharm."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922003546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922003546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:37:20Z","timestamp":1759163840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922003546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":63,"alternative-id":["S0168365922003546"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.05.059","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms of cellular retention of melanin bound drugs: Experiments and computational modeling","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.05.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}